PROTALIX BIOTHERAPEUTICS INC's ticker is PLX and the CUSIP is 74365A101. A total of 34 filers reported holding PROTALIX BIOTHERAPEUTICS INC in Q1 2016. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $9,000 | +12.5% | 13,096 | 0.0% | 0.00% | – |
| Q3 2017 | $8,000 | -27.3% | 13,096 | 0.0% | 0.00% | – |
| Q2 2017 | $11,000 | -95.8% | 13,096 | -97.8% | 0.00% | – |
| Q4 2016 | $260,000 | – | 584,793 | +2923865.0% | 0.00% | – |
| Q1 2016 | $0 | – | 20 | 0.0% | 0.00% | – |
| Q4 2015 | $0 | – | 20 | 0.0% | 0.00% | – |
| Q3 2015 | $0 | – | 20 | 0.0% | 0.00% | – |
| Q2 2015 | $0 | – | 20 | 0.0% | 0.00% | – |
| Q1 2015 | $0 | – | 20 | 0.0% | 0.00% | – |
| Q4 2014 | $0 | – | 20 | -88.2% | 0.00% | – |
| Q3 2014 | $0 | -100.0% | 170 | -70.2% | 0.00% | – |
| Q2 2014 | $2,000 | -33.3% | 570 | -30.1% | 0.00% | – |
| Q1 2014 | $3,000 | -70.0% | 816 | -68.1% | 0.00% | – |
| Q4 2013 | $10,000 | -9.1% | 2,560 | 0.0% | 0.00% | – |
| Q3 2013 | $11,000 | +175.0% | 2,560 | +191.2% | 0.00% | – |
| Q2 2013 | $4,000 | – | 879 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Camber Capital Management LP | 13,275,000 | $8,496,000 | 0.41% |
| Broadfin Capital, LLC | 2,025,268 | $1,296,000 | 0.13% |
| Baillie Gifford | 6,361,364 | $4,071,000 | 0.01% |
| Spark Investment Management LLC | 73,200 | $46,000 | 0.00% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 302,588 | $194,000 | 0.00% |
| WEDBUSH SECURITIES INC | 18,000 | $12,000 | 0.00% |
| Financial Architects, Inc | 10,000 | $6,000 | 0.00% |
| Psagot Value Holdings Ltd. | 22,050 | $14,000 | 0.00% |
| BARCLAYS PLC | 629,591 | $403,000 | 0.00% |
| CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM | 800,900 | $513,000 | 0.00% |